Harmony Biosciences Holdings Inc

2026. okt. 5. 20:01 UTC

Harmony Biosciences Holdings Inc is trading higher, continuing a trend of higher closes over the past three sessions, despite an earlier pullback.

2026. okt. 2. 20:07 UTC

Harmony Biosciences Holdings Inc shares are advancing amid a positive market environment and declining U.S. Treasury yields, reflecting routine performance since Thursday.

2026. okt. 1. 20:02 UTC

Harmony Biosciences Holdings Inc. shares are advancing following an analyst's price target increase to $42 and a planned poster presentation at the 17th European Narcolepsy Days.

2026. szept. 30. 22:10 UTC

Harmony Biosciences Holdings Inc is declining in after-market trading, reversing an earlier gain and continuing a trend of four consecutive lower closes.

2026. szept. 29. 20:12 UTC

Harmony Biosciences Holdings Inc traded modestly higher during after-market hours on Tuesday, despite remaining below its 20-day moving average.

2026. szept. 28. 20:07 UTC

Harmony Biosciences Holdings Inc shares fell sharply, reflecting a notable decline since Friday and trading well below its 20-day moving average.

2026. szept. 25. 20:07 UTC

Harmony Biosciences Holdings Inc is moving higher amid broad market gains, despite a flat price change since Thursday's close.

2026. szept. 24. 20:07 UTC

Harmony Biosciences Holdings Inc is trading higher as the broader market shows notable strength, achieving a significant rally since Wednesday's close.

2026. szept. 23. 20:07 UTC

Harmony Biosciences Holdings Inc shares fell sharply, pulling back from an earlier spike and contributing to a significant decline since Tuesday's close.

2026. szept. 22. 19:45 UTC

Harmony Biosciences Holdings Inc shares fell sharply after an early gain, currently trading below Monday's close but above the 20-day moving average.

2026. szept. 21. 21:10 UTC

Harmony Biosciences Holdings Inc is experiencing a significant decline in after-market trading, moving lower since Monday's close amid notable volatility.

2026. szept. 18. 21:11 UTC

Harmony Biosciences Holdings Inc is experiencing a significant decline in after-market trading, moving lower from a minor peak shortly after Friday's close.

2026. szept. 17. 23:16 UTC

Harmony Biosciences Holdings Inc saw a modest increase in after-market trading, positioned above its 20-day moving average and near its one-month range high.

2026. szept. 16. 23:06 UTC

Harmony Biosciences' WAKIX® receives approval from Japan's Ministry of Health for treating excessive daytime sleepiness, contributing to a modest after-market gain.

2026. szept. 15. 21:01 UTC

Harmony Biosciences Holdings Inc shares are trading higher in after-market hours, reflecting strong momentum despite no specific company news.

2026. szept. 14. 20:08 UTC

Harmony Biosciences is higher during Monday's session, reflecting broader market gains since Friday. The stock pulled back from an earlier session high.

2026. szept. 11. 22:56 UTC

Harmony Biosciences Holdings Inc is trading higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

2026. szept. 9. 20:07 UTC

Harmony Biosciences Holdings Inc shares are lower during Wednesday's session, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

2026. szept. 8. 20:13 UTC

Harmony Biosciences Holdings Inc is higher in after-market trading, supported by solid performance above its 20-day moving average and nearing its one-month trading range.

2026. szept. 3. 20:02 UTC

Harmony Biosciences announced it will present EPX-100 data at a future congress. Shares are trading lower, reversing from an earlier session high.

2026. szept. 2. 20:01 UTC

Harmony Biosciences Holdings Inc is higher today, reflecting positive market response despite no specific news. Broader market context includes slower job growth reported by ADP.

2026. szept. 1. 23:01 UTC

Harmony Biosciences Holdings Inc shares are higher in after-market trading, continuing an upward trend from three consecutive sessions of gains. No specific news was identified.

2026. aug. 31. 22:06 UTC

Harmony Biosciences shares are higher in after-market trading, rebounding from an initial dip amid geopolitical tensions affecting broader market conditions.

2026. aug. 28. 20:07 UTC

Harmony Biosciences Holdings Inc shares are lower during Friday's session, continuing a decline since Thursday's close amid no specific news to explain the downturn.

2026. aug. 27. 19:56 UTC

Harmony Biosciences will participate in the 2026 Cantor Global Healthcare Conference. Shares are higher today, reflecting positive market sentiment since Wednesday's close.

2026. aug. 26. 20:08 UTC

Wolfe Research initiated coverage on Harmony Biosciences with an Outperform rating and a $60 price target, contributing to higher shares during Wednesday's session.

2026. aug. 25. 19:26 UTC

Shares of Harmony Biosciences Holdings Inc. are modestly higher, trading within a narrow range amid routine performance during Tuesday's session.

2026. aug. 24. 21:01 UTC

Harmony Biosciences Holdings Inc is trading higher in after-market hours, reflecting a broader rebound in the bond market as Treasury yields decline.

2026. aug. 21. 22:31 UTC

Harmony Biosciences Holdings Inc. is trading higher in after-market hours, reaching the upper end of its one-month range and above the 20-day moving average.

2026. aug. 20. 23:31 UTC

Harmony Biosciences Holdings Inc shares are higher in after-market trading, supported by strong momentum above the 20-day moving average and within its one-month range.